Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Renal Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00747305
What this trial is testing

Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery

Who this might be right for
Kidney Cancer
Harry Drabkin 17
Testing effectiveness (Phase 2)Ended earlyNCT00467077
What this trial is testing

Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
California Cancer Consortium 21
Not applicableLooking for participantsNCT06206707
What this trial is testing

FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis

Who this might be right for
DiarrheaColitisMalignant Melanoma+1 more
University of Aarhus 20
Large-scale testing (Phase 3)Study completedNCT00416429
What this trial is testing

Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Centre Leon Berard 456
Testing effectiveness (Phase 2)UnknownNCT02072031
What this trial is testing

Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC）

Who this might be right for
AnlotinibRCC
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 133
Early research (Phase 1)Study completedNCT01714765
What this trial is testing

Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Cancer
Queen Mary University of London 17
Not applicableActive Not RecruitingNCT07332923
What this trial is testing

Predicting HIF-2α Levels in Clear Cell Kidney Cancer Using Machine Learning

Who this might be right for
Renal Clear Cell CarcinomaHIF-2αRadiomics+1 more
First Affiliated Hospital of Fujian Medical University 500
Not applicableStudy completedNCT01896778
What this trial is testing

Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer

Who this might be right for
Adult Liver CarcinomaBreast CarcinomaColon Carcinoma+7 more
Roswell Park Cancer Institute 9
Testing effectiveness (Phase 2)Ended earlyNCT00698685
What this trial is testing

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaHodgkin's Disease+3 more
University of Arizona 14
Testing effectiveness (Phase 2)UnknownNCT02787915
What this trial is testing

DC1s-CTL Cellular Therapy for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Xuzhou Medical University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05128487
What this trial is testing

NDI 1150-101 in Patients With Solid Tumors

Who this might be right for
Solid TumorRenal Cell Carcinoma (Kidney Cancer)Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+1 more
Nimbus Saturn, Inc. 106
Testing effectiveness (Phase 2)Ended earlyNCT00485563
What this trial is testing

A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Endocyte 12
Not applicableStudy completedNCT01404104
What this trial is testing

Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
St. Joseph's Healthcare Hamilton 11
Testing effectiveness (Phase 2)Study completedNCT01566747
What this trial is testing

Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5

Who this might be right for
Renal Cell Carcinoma
Cancer Trials Ireland 43
Large-scale testing (Phase 3)Ended earlyNCT03408652
What this trial is testing

Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted Therapies

Who this might be right for
Metastatic Renal Cell Carcinoma
Centre Leon Berard 1
Early research (Phase 1)Not Yet RecruitingNCT07500805
What this trial is testing

UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma

Who this might be right for
CD70-positive Advanced Renal Clear Cell Carcinoma
UTC Therapeutics Inc. 21
Testing effectiveness (Phase 2)UnknownNCT05124431
What this trial is testing

Anlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Fudan University 30
Not applicableUnknownNCT05005195
What this trial is testing

Yorkshire Kidney Screening Trial

Who this might be right for
Renal Cell Carcinoma
University of Leeds 5,850
Very early researchStudy completedNCT03071328
What this trial is testing

INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)Metastatic Urothelial CarcinomaMetastatic Renal Cell Carcinoma
Duke University 10
Testing effectiveness (Phase 2)Ended earlyNCT02959554
What this trial is testing

Study in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease Control

Who this might be right for
Metastatic Renal Cell Carcinoma
AIO-Studien-gGmbH 49
Next Page